Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
EPIC: GDR
Market: AIM:GDR
52-week High/Low: 42.00p / 25.00p
Sector: Pharma & Biotech
Market Cap: 7.01M
Genedrive PLC (:GDR)

Genedrive PLC

Genedrive® is our rapid and low cost molecular diagnostics platform for the identification and treatment selection of infectious diseases, human genotyping, animal health, pathogen identification, and other applicationsent and improving prognosis.

Genedrive PLC

www.genedrive.com

Interactive graph

col 3
col 4
col 5
col 6

Genedrive PLC RNS Announcements

Date Epic Announcement
11/06/2018 GDR Completion of Disposal
04/06/2018 GDR Result of General Meeting
17/05/2018 GDR Circular re Proposed Disposal
14/05/2018 GDR Proposed disposal for up to £1.9 million in cash
10/05/2018 GDR Holding(s) in Company
18/04/2018 GDR genedrive plc to Present at the UK Investor Show
10/04/2018 GDR Publication of Genedrive Performance Data in Gut
09/04/2018 GDR Directorate Change
04/04/2018 GDR Director/PDMR Shareholding
03/04/2018 GDR Genedrive® Hepatitis C test in Asia Pacific
27/03/2018 GDR genedrive signs distribution agreement for India
20/03/2018 GDR Holding(s) in Company
20/03/2018 GDR Interim Results
13/03/2018 GDR Commercial sales of Genedrive® HCV ID Kit begin
27/02/2018 GDR genedrive Receives Funding for TB Test Development
14/02/2018 GDR Notice of Results
18/01/2018 GDR Hardman Res: Hep-C point-of-care test launched
17/01/2018 GDR Holding(s) in Company
17/01/2018 GDR Trading update
16/01/2018 GDR First Successful Field Evaluation of HCV Assay
13/12/2017 GDR Hardman Research: Remodelled for growth
07/12/2017 GDR Director/PDMR Shareholding
29/11/2017 GDR Result of AGM
21/11/2017 GDR genedrive plc awarded Innovate UK grant
17/11/2017 GDR 2017 Annual Report and AGM Notice
14/11/2017 GDR Distribution agreement with Sysmex Asia Pacific
08/11/2017 GDR Directorate Change
06/11/2017 GDR Holding(s) in Company
02/11/2017 GDR Distribution update for India
23/10/2017 GDR Launches Genedrive® Hepatitis C test in Africa

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use